Harnessing the power of your skin microbiome
Our unique technology and novel actives provide an innovative and effective approach to skin health - unleash the full potential of your skin microbiome, just as nature intended it.
Today we are excited to announce that S-Biomedic joins Beiersdorf, a global leader in high-quality skin care products. We have been working with Beiersdorf as an investor and as a business partner since 2018. Following years of successful cooperation we are proud to announce a new chapter in our journey.
Behind our discovery
Restoring balance in the skin microbiome
The skin microbiome and the host form an ecosystem that has co-evolved for millions of years to adapt to environmental conditions for increased fitness.
As such, imbalances within our skin microbiome are associated with a wide variety of skin conditions such as acne, eczema, and rosacea.
Targeted modulation of the human microbiome offers the potential for revolutionary therapy.
Harnessing the power of your skin microbiome, S-Biomedic has made the skin the focus of its microbiome research and development.
Our technology
Living Skin Probiotics to address skin conditions
Our Living Skin Probiotics come from the major skin microbe itself; Cutibacterium.
Did you know that ‘Cutis’ is latin for‘living skin’?
As Living Skin Probiotics come from the skin, they can actually live on the skin, enabling the recovery of a healthy microbiome community. This opens the door to help our skin age healthy and address acne and other unsolved skin disorders.
The First Living Skin Probiotic Program
Sencyr® microbiome care that is alive.
Just like your skin.
Powered by the technology of the skin microbiome itself, our pioneering skin microbiome care program modulates and resets the acne-prone skin.
Our partners
The project Skin Microbiome has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 890930.
Flanders Innovation & Entrepreneurship support innovation and entrepreneurship, and contribute to a favourable business climate in Flanders.
“We modulate the population of skin bacteria so that the skin can return to its natural and healthy state.”
— Bernhard Paetzold PhD, Chief Scientific Officer and Co-founder of S-Biomedic
Meet our team
Veronika Oudova
Chief Executive Officer & Co-founder
Bernhard Paetzold
Chief Scientific Officer & Co-founder
Marc Guëll
Scientific Director & Co-founder
Get in touch
If you’d like to hear more about what we do at S-Biomedic, or have a question for our team, drop us a line and we would love to get in touch with you.